Cite

HARVARD Citation

    Blazejak, C. et al. (n.d.). Low-dose gemcitabine therapy in CTCL: 'real-life" data of the German Cutaneous Lymphoma Network. European journal of cancer. pp. S30-S31. [Online]. 
  
Back to record